Camson Bio Technologies Ltd

Camson Bio Technologies Ltd

₹ 3.31 -1.78%
11 May 2020
About

Camson Bio Technologies is engaged in the Business of Agricultural Biotech Products.

  • Market Cap 9.93 Cr.
  • Current Price 3.31
  • High / Low /
  • Stock P/E
  • Book Value 14.9
  • Dividend Yield 0.00 %
  • ROCE -19.2 %
  • ROE -39.3 %
  • Face Value 10.0

Pros

  • Stock is trading at 0.22 times its book value

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -49.4% over past five years.
  • Company has a low return on equity of -25.8% over last 3 years.
  • Company might be capitalizing the interest cost
  • Company has high debtors of 512 days.
  • Working capital days have increased from 329 days to 731 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Miscellaneous Industry: Miscellaneous

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2016 Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019
2.05 2.19 5.39 1.14 11.27 4.70 3.85 -0.51 1.29 1.52 1.58 0.59 1.19
6.33 5.18 11.74 1.72 7.11 4.88 4.83 2.47 1.85 2.90 1.24 15.38 6.72
Operating Profit -4.28 -2.99 -6.35 -0.58 4.16 -0.18 -0.98 -2.98 -0.56 -1.38 0.34 -14.79 -5.53
OPM % -208.78% -136.53% -117.81% -50.88% 36.91% -3.83% -25.45% -43.41% -90.79% 21.52% -2,506.78% -464.71%
0.53 0.59 0.58 0.22 0.69 0.62 0.23 -0.24 0.00 0.06 2.31 0.82 0.00
Interest 1.12 1.02 2.46 0.59 1.23 1.15 3.04 -0.06 1.73 2.27 2.11 -4.97 0.29
Depreciation 1.87 1.89 1.88 0.31 1.80 1.84 1.80 1.75 1.74 1.76 1.76 1.71 1.73
Profit before tax -6.74 -5.31 -10.11 -1.26 1.82 -2.55 -5.59 -4.91 -4.03 -5.35 -1.22 -10.71 -7.55
Tax % 2.52% 3.01% -3.86% 0.00% 0.00% 0.00% 0.00% 0.00% 5.71% 6.36% -46.72% 5.51% 0.00%
-6.91 -5.47 -9.72 -1.26 1.82 -2.55 -5.58 -4.90 -4.26 -5.69 -0.65 -11.30 -7.54
EPS in Rs -2.30 -1.82 -3.24 -0.42 0.61 -0.85 -1.86 -1.63 -1.42 -1.90 -0.22 -3.77 -2.51
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
33 39 65 85 95 117 140 157 24 9 18 5 5
24 29 47 62 73 89 116 141 39 23 18 21 26
Operating Profit 9 10 18 23 22 28 25 16 -14 -13 0 -16 -21
OPM % 27% 25% 27% 26% 23% 24% 18% 10% -59% -141% 0% -350% -438%
0 0 0 1 0 0 -3 6 1 4 1 3 3
Interest 0 0 0 0 0 2 4 4 5 7 5 1 -0
Depreciation 1 1 2 1 2 3 5 13 22 7 7 7 7
Profit before tax 8 8 16 22 20 23 13 5 -40 -23 -11 -21 -25
Tax % 3% 5% 7% 2% -1% 0% -5% 39% -5% -1% 0% 3%
8 8 15 22 21 23 13 3 -38 -23 -11 -22 -25
EPS in Rs 7.95 5.92 9.41 12.16 11.45 12.71 5.27 1.03 -12.61 -7.68 -3.74 -7.30 -8.40
Dividend Payout % 0% 17% 11% 8% 9% 8% 19% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: -19%
5 Years: -49%
3 Years: -42%
TTM: -48%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 12%
TTM: -46%
Stock Price CAGR
10 Years: %
5 Years: -7%
3 Years: %
1 Year: %
Return on Equity
10 Years: 1%
5 Years: -14%
3 Years: -26%
Last Year: -39%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
Equity Capital 10 14 16 18 18 18 25 30 30 30 30 30
Reserves 18 26 59 89 107 143 202 234 74 47 37 15
2 1 1 1 12 41 40 37 47 46 49 50
2 6 9 23 15 14 16 25 21 24 26 28
Total Liabilities 32 47 85 131 153 217 282 325 172 147 142 122
13 18 29 27 35 78 110 139 106 95 88 81
CWIP 0 0 6 11 22 0 0 0 0 0 0 0
Investments 0 0 1 4 0 0 0 0 6 3 3 3
19 28 50 89 96 138 173 187 60 49 50 37
Total Assets 32 47 85 131 153 217 282 325 172 147 142 122

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
2 1 10 -2 10 -13 -15 14 -10 5 2 0
-6 -7 -19 -21 -20 -25 -36 -43 5 3 1 -0
2 5 22 10 9 39 51 28 4 -7 -3 -0
Net Cash Flow -2 -0 14 -13 -1 1 0 -1 -0 -0 0 -0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
Debtor Days 54 69 66 182 180 199 218 342 249 145 101 512
Inventory Days 421 481 564 734 543 386 218 121 697 1,766 1,847 628
Days Payable 33 31 10 237 102 27 19 51 517 1,105 378 185
Cash Conversion Cycle 442 519 619 679 621 559 417 412 428 806 1,570 955
Working Capital Days 165 201 149 275 293 306 293 373 120 -192 448 731
ROCE % 33% 24% 28% 24% 17% 15% 9% 3% -15% -12% -5% -19%

Shareholding Pattern

Numbers in percentages

Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019
24.46% 24.46% 24.46% 24.46% 24.46% 24.46% 24.46% 24.46% 24.46% 24.46% 24.46% 24.46%
19.57% 19.81% 19.81% 19.81% 19.81% 19.81% 19.81% 19.81% 19.81% 19.57% 19.57% 19.57%
1.98% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
53.99% 55.73% 55.73% 55.73% 55.73% 55.73% 55.73% 55.73% 55.73% 55.97% 55.97% 55.97%
No. of Shareholders 11,36811,38410,99310,75210,0509,8719,7409,6289,6069,4839,3209,221

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents